Gouvernance Pfizer, Inc.

PFE

US7170811035

Produits pharmaceutiques

Marché Fermé - Nyse Autres places de cotation 22:00:08 13/09/2024			Après clotûre 23:14:54
29,27 ^USD	+0,38 %		29,22	-0,19 %

19:28	Moderna fait face à des "vents contraires importants" sur le VRS et le COVID, selon RBC	MT
09:05	Valneva chute en Bourse après une levée de fonds dilutive	DJ

Comité Exécutif: Pfizer, Inc.

Dirigeant

Fonctions occupéesDepuis

Albert Bourla

62 ans

Chief Executive Officer

01/01/2019

Mikael Dolsten

65 ans

Chief Tech/Sci/R&D Officer

01/12/2010

Payal Sahni Becher

Human Resources Officer

01/01/1997

Aida Habtezion

Chief Tech/Sci/R&D Officer

01/01/2021

Gordon Loh

Comptroller/Controller/Auditor

01/03/2020

Jennifer Damico

56 ans

Comptroller/Controller/Auditor

01/03/2020

Lidia Fonseca

55 ans

Chief Tech/Sci/R&D Officer

Christopher J. Stevo

Investor Relations Contact

19/07/2021

François-Maurice Garnier

62 ans

General Counsel

01/01/2003

Margaret M. Madden

General Counsel	-
Corporate Secretary	-

Douglas Lankler

58 ans

General Counsel

01/12/2013

Rady Johnson

63 ans

Compliance Officer

01/12/2013

Jeff Settleman

Chief Tech/Sci/R&D Officer

01/07/2019

Bryan Supran

General Counsel

01/04/2016

Annaliesa Anderson

Chief Tech/Sci/R&D Officer

01/01/2007

David Denton

59 ans

Director of Finance/CFO

02/05/2022

Maria Rivas

60 ans

Chief Tech/Sci/R&D Officer

01/09/2022

Susan Rienow

45 ans

Sales & Marketing

Composition du Conseil d'Administration: Pfizer, Inc.

Administrateur

ComitésDepuis

Albert Bourla

62 ans

Executive Committee Chair

01/01/2020

Scott Gottlieb

51 ans

Executive Committee	27/06/2019
Governance Committee	29/10/2019
Nominating Committee	29/10/2019
Compensation Committee	04/02/2020
Governance Committee Chair	04/02/2020
Nominating Committee Chair	04/02/2020

Ronald Blaylock

64 ans

Compensation Committee	23/02/2017
Governance Committee	01/01/2001
Nominating Committee	01/01/2001
Compensation Committee Chair	17/10/2007
HR Committee Chair	17/10/2007
Audit Committee	23/02/2017

Joseph Echevarria

66 ans

Audit Committee	25/06/2015
Governance Committee	01/04/2016
Nominating Committee
Finance Committee Chair
Executive Committee	25/06/2015
Governance Committee Chair	25/06/2015

Suzanne Johnson

66 ans

Executive Committee	01/09/2007
Audit Committee Chair	01/09/2007
Governance Committee	20/01/2022
Nominating Committee	20/01/2022
Compensation Committee Chair	20/01/2022

Cyrus Taraporevala

58 ans

Audit Committee	27/06/2024
Compensation Committee	27/06/2024
Nominating Committee	14/12/2023

Jim Smith

64 ans

Audit Committee	26/06/2014
Executive Committee	26/06/2014
Compensation Committee Chair	26/06/2014

Helen Hobbs

71 ans

Executive Committee	12/12/2011
Governance Committee	18/04/2012

James Quincey

59 ans

Executive Committee Chair	24/04/2019
Compensation Committee	27/02/2020

Sue Desmond-Hellmann

66 ans

Governance Committee

01/01/2020

Dan Littman

71 ans

Governance Committee

05/03/2018

Shantanu Narayen

60 ans

Executive Committee

27/09/2013

Susan Hockfield

73 ans

Director/Board Member	04/03/2020
Independent Dir/Board Member	04/03/2020

Dernières Nominations: Pfizer, Inc.

Rocket Pharmaceuticals, Inc. nomme Mikael Dolsten au conseil d'administration	11/09	CI
Pfizer nomme Elif Aral Présidente régionale pour le Moyen-Orient, la Russie et l'Afrique (MERA)	05/09	CI
Volcano Spring International Holdings Limited annonce la nomination de Zheng Jingwen en tant qu'administrateur non exécutif	02/09	CI
OS Therapies Incorporated nomme Borys Shor à son comité consultatif sur les anticorps conjugués à des médicaments (ADC)	22/08	CI
Genmab A/S annonce des changements au sein de son comité exécutif	16/08	CI
Oculis Holding AG nomme Sharon Klier au poste de directrice du développement	15/08	CI
Atara Biotherapeutics, Inc. annonce le changement de son PDG à compter du 9 septembre 2024	12/08	CI

Plus d'Actualités

Anciens Dirigeants et Administrateurs: Pfizer, Inc.

Insider

Fonctions occupées

DepuisJusqu'au

Frank D'Amelio

Director of Finance/CFO	01/09/2007	01/06/2020
Corporate Officer/Principal	01/06/2020	01/12/2021

James Kilts

Director/Board Member	01/09/2007	16/11/2020
Independent Dir/Board Member	01/09/2007	16/11/2020

Wyllie Cornwell

Director/Board Member	01/02/1997	16/11/2020
Independent Dir/Board Member	01/02/1997	16/11/2020

Loretta V. Cangialosi

Comptroller/Controller/Auditor

01/03/2020

Dennis Ausiello

Director/Board Member	01/12/2006	25/04/2019
Chairman	25/05/2011	25/05/2011
Independent Dir/Board Member	23/04/2015	25/04/2019

George A. Lorch

Director/Board Member	01/06/2000	23/04/2015
Chairman	14/12/2010	13/12/2011
Independent Dir/Board Member	05/04/2011	23/04/2015

M. Anthony Burns

Director/Board Member	01/01/1988	19/12/2013
Independent Dir/Board Member	24/05/2011	19/12/2013

William Herbert Gray

Director/Board Member	01/06/2000	01/07/2013
Independent Dir/Board Member	24/05/2011	01/07/2013

Michael Brown

Director/Board Member	01/01/1996	01/04/2012
Independent Dir/Board Member	24/05/2011	01/04/2012

Briggs Morrison

Chief Tech/Sci/R&D Officer

01/10/2007

01/12/2011

Neil Gibson

Corporate Officer/Principal

01/01/2007

01/01/2011

Jeffrey Kindler

Director/Board Member	01/03/2005	31/07/2006
Chief Executive Officer	31/07/2006	05/12/2010
Chairman	19/12/2006	05/12/2010
General Counsel	01/01/2002	31/07/2006
Corporate Officer/Principal	01/01/2002	01/03/2005

Richard Bagger

Public Communications Contact

01/01/2006

01/01/2010

John LaMattina

Corporate Officer/Principal

01/01/2004

01/12/2008

Allen Waxman

General Counsel

01/01/2003

11/03/2008

David Shedlarz

Director/Board Member	01/07/2005	01/12/2007
Director of Finance/CFO	01/01/1999	01/07/2005
Corporate Officer/Principal	01/07/2005	01/12/2007

Alan Levin

Director of Finance/CFO	01/01/1987	01/09/2007
Treasurer	01/01/1987	01/09/2007

Ruth Simmons

Director/Board Member

01/01/1997

26/04/2007

Stanley O. Ikenberry

Director/Board Member

01/10/2005

22/03/2007

Karen Katen

Director/Board Member

01/01/1974

01/01/2007

Eliot Forster

Corporate Officer/Principal

01/01/1996

01/01/2007

Sharon Real

Corporate Officer/Principal

01/01/2000

01/01/2006

Jean-Paul Vallès

Director/Board Member

01/01/1980

23/06/2005

Yvonne R. Jackson

Human Resources Officer

01/07/2002

01/06/2005

Franklin Raines

Director/Board Member	01/10/1998	28/04/2005
Director/Board Member	01/01/1993	01/01/1996

Yoshihiro Toyohara

Corporate Officer/Principal

01/01/2003

01/01/2005

Brian Goldberg

Corporate Officer/Principal

01/06/2002

30/09/2004

William J. Creelman

Comptroller/Controller/Auditor

01/01/2003

01/01/2004

Lynne E. Weissberger

Director/Board Member

01/04/1996

01/12/2003

William H. D. Horton

Public Communications Contact

01/07/2002

01/09/2003

Pat Parr

Corporate Officer/Principal

01/01/1997

01/04/2003

George Milne

Director/Board Member	01/01/1984	01/01/1985
Chief Tech/Sci/R&D Officer	01/01/1970	01/01/2002

Warren R. Winter

Chief Tech/Sci/R&D Officer

01/01/1986

31/12/2001

Emmett Cunningham

Corporate Officer/Principal

31/12/2001

Wendell Wierenga

Corporate Officer/Principal

01/01/1990

01/07/2000

Michael Berendt

Corporate Officer/Principal

01/01/1982

01/01/2000

Richard G. Minicus

Corporate Officer/Principal

30/12/1998

John T. Boris

Corporate Officer/Principal

02/01/1988

01/01/1998

Dilip J. Mehta

Corporate Officer/Principal

01/01/1982

Mark A. Braman

Corporate Officer/Principal

01/01/1984

01/01/1996

Jonathan R. McGrath

Chief Tech/Sci/R&D Officer

01/01/1990

01/01/1995

Henrik Rasmussen

Corporate Officer/Principal

01/01/1989

01/12/1994

Andrew B. McCormick

Public Communications Contact

01/01/1993

Robert Cohen

Corporate Officer/Principal

01/01/1981

01/01/1992

Gene Clapp

Corporate Officer/Principal

31/12/1987

Sylvia Montero

Human Resources Officer

01/01/1978

Theodore Matthew Thome

Corporate Officer/Principal

Jay Lichter

Corporate Officer/Principal

Albert Michael Davis

Corporate Officer/Principal

Malcolm Kahn

Comptroller/Controller/Auditor	-	-
Sales & Marketing	-	-

Jean-Michel Hotton

Corporate Officer/Principal

Peter Rost

Corporate Officer/Principal

Daniel Cushing

Corporate Officer/Principal

John Nicastro

Sales & Marketing

Mike E. Pape

Corporate Officer/Principal

Robert H. Driver

Corporate Officer/Principal

Andrew Hertzmark

Corporate Officer/Principal

Robert W. Norton

Corporate Officer/Principal

Shreya Prudlo

Public Communications Contact

Ali Shirazi

Corporate Officer/Principal

Gabriela G. Cezar

Corporate Officer/Principal

John W. Mitchell

Corporate Officer/Principal

Raul E. Kohan

Comptroller/Controller/Auditor

Tyana Kurtz

Sales & Marketing

David McGibney

Corporate Officer/Principal

Alan Lang

Corporate Officer/Principal

Steve Kennedy

Corporate Officer/Principal

Donald R. Sellers

Corporate Officer/Principal

Dennis J. Block

Corporate Officer/Principal

Howard Zauberman

Corporate Officer/Principal

Pierre E. G. Etienne

Chief Operating Officer

Robert L. Mallett

Public Communications Contact

Michael Petrarca

Corporate Officer/Principal

Stephen Arneric

Corporate Officer/Principal

James W. Larson

Human Resources Officer

Nancy Ramamurthi

Corporate Officer/Principal

Leonard C. Stephens

Human Resources Officer

Richard A. Lotti

Corporate Officer/Principal

Anup Arora

Corporate Officer/Principal

Andrew McDonald

Corporate Officer/Principal

Charles L. Hardwick

Public Communications Contact

01/01/1966

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	39
Femme	10

Dont comité exécutif

Homme	13
Femme	5

Dont Administrateurs

Homme	12
Femme	1

ESG Refinitiv

C+

Environnement

Emissions

Innovation

Utilisation de ressources

Gouvernance

Stratégie RSE

Management

Actionnaires

Polémique

Pfizer, Inc. est le 1er groupe pharmaceutique mondial. Le CA par famille de produits se répartit comme suit : - produits de soins primaires (72,8%) : médicaments utilisés en médecine interne, vaccins, médicaments pour la prévention et le traitement du Covid-19, antiviraux, produits à base d'ARNm, etc. ; - produits de soins spécialisés (13,8%) : médicaments utilisés en immunologie, en milieu hospitalier et pour le traitement des maladies rares, médicaments anti-inflammatoires, etc. ; - produits utilisés en oncologie (12,1%); - autres (1,3%). A fin 2022, le groupe dispose de plus de 35 sites de production dans le monde. La répartition géographique du CA est la suivante : Etats-Unis (42,3%), Europe (21,9%) et autres (35,8%).

Employés

88 000

Secteur

Produits pharmaceutiques

Agenda

16:00 - European Society for Medical Oncology Meeting - Abstract No: 607O

Plus d'informations sur la société